Table 3.
Factors affecting CR by logistic regression model analysis
Parameters | Logistic regression | |||
---|---|---|---|---|
P value | OR | 95% CI | ||
Lower | Higher | |||
Univariate logistic regression | ||||
Age (≥60 y vs <60 y) | 0.994 | 0.996 | 0.366 | 2.713 |
Gender (male vs female) | 0.917 | 0.943 | 0.310 | 2.870 |
Relapsed vs de novo | 0.847 | 1.123 | 0.345 | 3.649 |
Number of nodules (≥2 vs 1) | 0.001 | 0.137 | 0.044 | 0.430 |
Largest nodule size (≥5 cm vs <5 cm) | 0.033 | 0.325 | 0.115 | 0.913 |
Child‐Pugh stage (B vs A) | 0.774 | 1.261 | 0.258 | 6.168 |
BCLC stage (B/C vs A) | 0.005 | 0.215 | 0.074 | 0.628 |
Cycles of DEB‐TACE (≥2 vs 1) | 0.782 | 1.156 | 0.416 | 3.210 |
AFP (≥98.8 μg/L vs <98.8 μg/L) | 0.019 | 0.282 | 0.098 | 0.812 |
Multivariate logistic regression | ||||
Number of nodules (≥2 vs 1) | 0.001 | 0.141 | 0.045 | 0.443 |
Data were presented as P value, OR (odds ratio), and 95% CI (confidence interval). Factors affecting CR were determined by univariate and multivariate logistic regression model analyses, and the multivariate logistic regression model analysis was performed using Forward Stepwise (Conditional) method. P value <0.05 was considered significant, and the significant results were shown in boldface.
Abbreviations: AFP, alpha‐fetoprotein; BCLC, Barcelona Clinic Liver Cancer; CR, complete response; DEB‐TACE, drug‐eluting bead transarterial chemoembolization.